Roche finance chief steps down

January 17, 2011
Sales and Marketing Alan Hippe, Erich Hunziker, Roche, appointment, sales and marketing

Roche’s chief financial officer Erich Hunziker is to retire at the end of March after ten years with the company. …

Novo Nordisk's Victoza

Diabetes drugs show promise in Alzheimer’s

January 17, 2011
Research and Development Alzheimer's, Alzheimer’s, Byetta, Novo Nordisk, Victoza, diabetes, exenatide, lilly, liraglutide

Research suggests that new diabetes drugs enhance cell growth in the brain, and could help treat Alzheimer’s disease. Researchers at …

Blog footer

Digital Pharma: NHS thrombosis e-learning

January 14, 2011
Medical Communications Bayer, Boehringer Ingelheim, Digital Pharma blog, NHS training, Pfizer, Sanofi-Aventis, VTE, e-learning, venous thromboembolism

The NHS has launched a best-practice website to help educate healthcare professionals about one of the most common causes of …

Gates Foundation funds TB drug discovery

January 14, 2011
Research and Development Bill and Melinda Gates Foundation, IDRI, Infectious Disease Research Institute, Lilly TB Drug Discovery Initiative, TB, lilly, tuberculosis

Research to identify leads and drug targets for new tuberculosis treatments is to be funded by the Bill and Melinda …

GSK moves Crohn’s disease drug into phase III

January 14, 2011
Research and Development ChemoCentryx, Crohn’s disease, GSK’786, GlaxoSmithKline, Traficet-EN

GlaxoSmithKline and its partner ChemoCentryx have started late-stage trials of GSK’786 for Crohn’s disease. The initial study is a randomised, …

Publicis acquires French comms agency

January 14, 2011
Medical Communications Digital District, François Sarkozy, Healthcare Consulting, In-Sync, Publicis Healthcare Consulting, Resolute Communications, Yannick Sabatin, publicis

Paris-based communications giant Publicis Groupe has bought a health comms agency set up by the brother of French president Nicolas …

Anti-cancer stem cell drug starts clinical trials

January 14, 2011
Research and Development Cancer, GSK, GlaxoSmithKline, OMP-21M18, OMP-59R5, OncoMed, Stem cells, advanced solid tumour cancers

OncoMed and GSK’s novel anti cancer stem cell drug OMP-59R5 has begun clinical trials and could represent the future direction …

Red Health boosts account team

January 14, 2011
Medical Communications Jo Tubbs, Nicole Tripney, appointment, medical communications, red consultancy, red health

The Red Consultancy has started the year with two new hires for its specialist health team, Red Health. Account director …

GSK's UK headquarters

End of the line for GSK’s resveratrol

January 14, 2011
Research and Development GSK, GlaxoSmithKline, SRT2104, SRT2379, SRT501, Sirtris, multiple myeloma, resveratrol

GlaxoSmithKline is halting all work on resveratrol, a compound found in red wine and thought to have life extending properties. …

Watermeadow supports charity cycle ride

January 13, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

 Watermeadow is the proud sponsor of a team of Burford fire fighters and their colleagues who cycled 983 miles from …

zealand_pharma_hanne_leth_hillman

Hanne Leth Hillman joins Zealand Pharma

January 13, 2011
Medical Communications Hanne Leth Hillman, Zealand Pharma, appointment, medical communications

Danish biopharmaceutical company Zealand Pharma has appointed Hanne Leth Hillman as VP of investor relations and corporate communications. She will …

Aurobindo sells Chinese API unit to Sinopharm

January 13, 2011
Manufacturing and Production API, Aurobindo Pharma, China, Sinopharm Weiqida Pharmaceutical, active pharmaceutical ingredient

Indian company Aurobindo Pharma intends to sell off a loss-making active pharmaceutical ingredient unit to Sinopharm, the largest pharmaceutical company …

Kaiser Permanente

Learning from other healthcare models

January 13, 2011
CapGemini, Kaiser Permanente, NHS, healthcare, integrated healthcare

When you need high quality healthcare that is also affordable, prevention is definitely better than cure. How can governments and …

Pfizer's Lipitor tablet

Pfizer lung cancer drug gets ‘rolling’ fast-track status in US

January 13, 2011
Sales and Marketing Cancer, NSCLC, axitinib, bosutinib, crizotinib, non-small cell lung cancer

Pfizer has initiated a ‘rolling’ submission for its new oral ALK lung cancer drug crizotinib that could see it on …

Czech reforms will cut drug spending

January 13, 2011
Sales and Marketing Czech Republic, Drug pricing, drug funding, drug spending, global pricing, healthcare reforms, medicines pricing

The Czech Republic has announced a major healthcare reform plan, including plans to restrict access to high cost new medicines. …

New cancer strategy gets £750 million boost

January 13, 2011
Cancer, NHS, cancer funding, cancer strategy

The government has published a new ‘Strategy for Cancer’ that seeks to increase preventive measures and improve outcomes for oncology …

GlaxoSmithKline's health coaching website

Digital Pharma: Pfizer launches Dutch prescription service

January 12, 2011
Medical Communications Digital Pharma blog, Holland, Pfizer, consumer healthcare, disease awareness campaigns, healthcare coaching, ilivi.nl, patient information

Pfizer has tied up with an online pharmacy to break new ground in patient services in Holland with ilivi.nl. The …

Amgen HQ

Amgen aims for oncology expansion and a wider denosumab license

January 12, 2011
Research and Development AMG- 479, AMG-386, Amgen, Cancer, Pancreatic cancer, denosumab, motasenib

Amgen is seeking to increase the use of its bone drug denosumab and further its reach into the oncology market, …

Call to share public health research more openly

January 12, 2011
Research and Development Bill and Melinda Gates Foundation, Wellcome Trust, data sharing, public health

The only way that pressing needs in global public health can be met is for research to be shared more …

Lilly and Boehringer sign major diabetes collaboration

January 12, 2011
Research and Development BI10773, Boehringer Ingelheim, Eli Lilly, LY2605541, LY2963016, TGF-beta monoclonal antibody, diabetes, lilly, linagliptin, type II diabetes

Eli Lilly and Boehringer Ingelheim have signed a multi-million dollar collaboration that will see them develop and commercialise a mid- …

The Gateway to Local Adoption Series

Latest content